1·The study also confirmed that adding fenofibrate to simvastatin did not result in any excess risk of myopathy (muscle problems), venous thrombosis or pancreatitis.
这项研究同样证实将非诺贝特加入辛伐他汀不会引起任何肌病(肌肉病变)，静脉血栓或胰脏炎等多余危害。
2·It is not known if the increased risk for myopathy observed in these patients applies to other patients of Asian descent.
目前尚不清楚在中国裔病人中观察到的肌病风险升高的问题是否也适用于亚裔人群。
3·The most serious form of myopathy is called rhabdomyolysis.
肌病最严重的形式被称作横纹肌溶解。
4·The risk of myopathy is also increased when simvastatin, especially at the higher doses, is used with certain drugs (see Simvastatin Dose Limitations below).
当辛伐他汀（特别是大剂量）与某些药物联合服用时，也会增加肌病的风险。
5·The polymorphisms of liver drug transporter 1B1 genes are associated with myopathy induced by stating.
肝脏药物转运体1B1基因多态性与他汀类药物致肌病有关；